- Home
- RCUS vs BBWI Comparison
RCUS vs BBWI Comparison
Compare RCUS & BBWI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RCUS | BBWI |
|---|---|---|
| Founded | 2015 | 1963 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Clothing/Shoe/Accessory Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 3.8B |
| IPO Year | 2018 | 1994 |
Fundamental Metrics
Financial Performance| Metric | RCUS | BBWI |
|---|---|---|
| Price | $17.47 | $21.40 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 15 | 18 |
| Target Price | ★ $41.00 | $24.93 |
| AVG Volume (30 Days) | 2.4M | ★ 6.0M |
| Earning Date | 11-04-2026 | 11-19-2026 |
| Dividend Yield | N/A | ★ 3.79% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.49 |
| Revenue | $247,000,000.00 | ★ $7,291,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.69 |
| P/E Ratio | ★ N/A | $14.18 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $17.43 | $14.28 |
| 52 Week High | $31.74 | $24.94 |
Technical Indicators
Market Signals| Indicator | RCUS | BBWI |
|---|---|---|
| Relative Strength Index (RSI) | 34.56 | 53.15 |
| Support Level | N/A | $17.60 |
| Resistance Level | $19.63 | $23.86 |
| Average True Range (ATR) | 0.95 | 0.82 |
| MACD | 0.16 | -0.25 |
| Stochastic Oscillator | 10.96 | 11.69 |
Price Performance
Historical ComparisonAbout RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat, Casdatifan, Zimberelimab, among others. The company operates in one reportable and operating segment, which is the business of developing and commercializing differentiated therapies.
About BBWI Bath & Body Works Inc.
Bath & Body Works is a specialty home fragrance and fragrant body care retailer operating under the Bath & Body Works, C.O. Bigelow, and White Barn brands. The company generates most of its business in North America, with just 4% of sales from international markets in fiscal 2025. For fiscal 2025, 77% of sales stemmed from the brick-and-mortar network of more than 1,900 retail stores, similar to 2024 levels, as consumer shopping patterns remained normal. Future growth is expected from store upgrades, digital and international channels, as well as adjacent category expansions like lip.